Results 221 to 230 of about 7,638,891 (308)
Response to the Letter Regarding "Reference Values for Weight, Height, Head Circumference, and Body Mass Index in Turkish Children". [PDF]
Bayrak Demirel Ö +2 more
europepmc +1 more source
References of references in Robotics. References of references in image processing board.
openaire +2 more sources
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu +3 more
wiley +1 more source
Accuracy of visual estimation of shoulder abduction by expert physiotherapists: a comparative study using 3D motion capture. [PDF]
Kenner M, Thies P, Schwarz A.
europepmc +1 more source
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant +11 more
wiley +1 more source
Correction: Synergistic antibacterial effects of postbiotics combined with linezolid and amikacin against nosocomial pathogens. [PDF]
Yaprak Çolak E, Duran N.
europepmc +1 more source
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
KCFtools: rapid alignment-free method for introgression screening and GWAS using k-mer profiles. [PDF]
Selvanayagam S +5 more
europepmc +1 more source

